1. Variations in anti-dementia drug prescribing
- Author
-
Amber Shingleton-Smith, Thomas R. E. Barnes, Sri Perecherla, and Carol Paton
- Subjects
Drug ,medicine.medical_specialty ,Pediatrics ,Drug Prescribing ,business.industry ,media_common.quotation_subject ,Context (language use) ,Primary care ,medicine.disease ,Psychiatry and Mental health ,Neurology ,Family medicine ,mental disorders ,medicine ,Dementia ,Neurology (clinical) ,Pshychiatric Mental Health ,Medical prescription ,business ,media_common - Abstract
In the context of a project to benchmark anti-dementia drug prescribing practice against standards derived from evidence-based guidelines, the authors sought to estimate the proportion of people with dementia who were receiving treatment with an anti-dementia drug and whether this varied across Primary Care Trust (PCT) populations.They also explored the relative proportion of prescriptions for each anti-dementia drug, and the source of these prescriptions – GPs,Mental HealthTrusts or acuteTrusts. Copyright © 2009 Wiley Interface Ltd
- Published
- 2009
- Full Text
- View/download PDF